[Therapeutic management of menometrorrhagia in hemostasis disorders].

Abstract

Numerous epidemiological studies have confirmed an association between disorder of hemostasis and menorrhagia with an incidence of von Willebrand factor deficiency of 13%, the most common underlying bleeding disorder. In this context, a multidisciplinary approach is the best model. Similarly, women using anticoagulant treatment are exposed to menorrhagia or metrorraghia. The research of both gynaecological disease and therapeutic overdose is necessary.

• Authors: G Plu-Bureau, M-H Horellou
• Journal: Journal de gynecologie, obstetrique et biologie de la reproduction (J Gynecol Obstet Biol Reprod (Paris)) Vol. 37 Suppl 8 Pg. S365-7 (Dec 2008) ISSN: 0368-2315 [Print] France
• Vernacular Title: Prise en charge thérapeutique des ménométrorragies liées aux coagulopathies et traitement anticoagulant.
• PMID: 19268215 (Publication Type: English Abstract, Journal Article)

Chemical References

• Anticoagulants

Topics

• Adult
• Anticoagulants (adverse effects)
• Blood Coagulation Disorders (chemically induced, complications)
• Female
• Humans
• Metrorrhagia (drug therapy, etiology, therapy)
• von Willebrand Diseases (complications, epidemiology)